The need for a population-based surveillance system for liver disease in the United States.
Novartis, Inc., Senior Epidemiologist, Clinical Safety and Epidemiology, One Health Plaza, East Hanover, NJ, USA.
Anila
A
Verma
David E
DE
Lilienfeld
D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000453:epidemiology* / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D017891:Pharmacoepidemiology; D011159:Population Surveillance; D018426:SEER Program; D014481:United States / Q000453:epidemiology